A Kyoto-based regenerative medicine company is launching a service that will allow individuals to generate and store induced pluripotent stem cells from their own blood for potential future use. Starting in April, iPS Portal Inc will offer a service in collaboration with pharmaceutical experts that features strict quality standards and…